ZKR Orthopedics’ LIFT implant Receives FDA Breakthrough Device Designation

Medically reviewed by Dr. Sabrina Strickland, MD · Orthopedic Surgeon, Hospital for Special Surgery · Last reviewed: February 29, 2024

February 21, 2024

I have been aware of the LIFT implant device for a few years but was excited to see a publication recently about its early results in Europe. Now the FDA has granted it breakthrough device status and we are optimistic that an FDA trial will be starting soon.

This minimally invasive surgery will involve implanting a small device or spacer to elevate the patellar tendon in patients with anterior knee pain due to patellar cartilage lesions and arthritis.

FDA breakthrough device designation, late-stage cartilage degeneration, LIFT implant, Osteoarthritis, pain, patella tendon, patellofemoral compartment, patellofemoral osteoarthritis, ZKR Orthopedics

Considering treatment for a knee or shoulder concern?

Dr. Sabrina Strickland sees patients at Hospital for Special Surgery in New York City. If you would like a personalized evaluation of your symptoms and options, request a consultation below.

Book an appointment Contact the office

Medical Disclaimer. This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified physician regarding any questions about your orthopedic health. Individual results may vary based on diagnosis, anatomy, and overall health.